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DIMETHYLNITROSAMINE (DMN) is a very powerful liver carcinogen for the rat
(Magee and Barnes, 1956) and will produce malignant tumours at other sites and
in other species (Magee and Barnes, 1967).
Because of the possible importance of certain nitrosamines as aetiological
agents for cancer in the human environment (Magee and Barnes, 1967) it was
important that an attempt should be made to try to obtain experimental data on
the basis of which it might be possible to calculate a non-effective dose of this
compound. This also required an evaluation of non-neoplastic lesions appearing
in animals exposed to the carcinogenic nitrosamine and their relation to tumour
development. The experiments reported here were carried out in this laboratory
since 1957 and dietary concentrations of DMN ranging between 2 and 50 p.p.m.
were used. No non-neoplastic lesions were found to be specifically linked with
the appearance oftumours. The findings are discussed in relation to the problem
of constructing the dose-response relationship of a powerful carcinogen which in
this case is probably produced within the animal body from the compound which
is added to the diet.
MATERIALS AND METHODS
Male and female white rats (Porton strain) 4-6 weeks old were housed 6 to a
cage. All rats were given Diet 41B (Bruce and Parkes, 1957) in powder form.
Food intake was measured throughout the experiments and the rats were weighed
twice weekly. All sick animals and any animal found to be losing weight were
killed with coal-gas.
DMN (British Drug Houses, Ltd.) was added to the powdered diet as a solution
in arachis oil. The solutions in oil were so made up that oil was added at the rate
of 10 ml. to each kilo of powdered diet and mixed in a Hobart food mixer. The
controls had oil alone added to their diet except for one group of 6 male and 6
female included from another experiment which were fed pellets. At intervals
during the earlier experiments the level of DMN in the diets was checked by the
method of Heath and Jarvis (1955). The amount of DMN was always within
20% of the expected concentration and it did not fall off within the periods
(1-2 weeks) during which the batches ofprepared diets were used.
Pathology
Autopsies were carried out shortly after death and the tissues fixed in either
Helly's solution or formol saline. Several pieces ofthe liver were removed and in
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most experiments both kidneys together with any other tissue appearing abnormal
at autopsy. The skull was opened and pituitary tumours and evidence of aural
sepsis sought.
Tissues were fixed, cleared and imbedded in the usual way. Sections were
cut at 7ct and stained by haematoxylin and eosin.
RESULTS
Details of the animals used in the various experiments are given in Table I.
Survivors at 104 weeks were usually killed; a few animals were left alive for up to
TABLE I.-Summary of the Experimental Animals Used in Various Experiments
in Which DMN was Given in the Diet
Conc. of DMN No. of animals
in the diet , Rats with
(p.p.m.) Sex At start After 60 weeks liver tumours
0 . M . 12 11 . 0
F 29 25 0
2 . M . 19 13 . 1
F 18 13 . 0
5 . M . 6 5 . 1
F 62 55 . 4
*5 F 15 14 . 3
10 . F 5 5 . 2
20 . F 23 13 . 15
50 . F . 12 0 . 10
* These rats received 5 p.p.m. in their diet for 52 weeks and then received a normal diet.
120 weeks. Deaths before 60 weeks in untreated rats and those on the lower
doses of DMN were due to intercurrent disease but on the higher doses (20 and
50 p.p.m.) were often due to liver tumours.
In one experiment animals received 5 p.p.m. DMN for only 52 weeks and were
then returned to a normal diet and compared with those fed DMN at this level
continuously. Six rats were killed at 52 weeks for examination of the liver.
Because DMN can produce kidney tumours in rats under some conditions (Magee
and Barnes, 1962) special attention was paid to the kidneys. No tumours visible
to the naked eye were found at autopsy but a search was made for histological
evidence of early lesions or other damage.
A complete autopsy was carried out on all but 2 of the rats but in a further 5
no histological material was prepared because of the advanced decomposition at
the time of autopsy.
Pathological Changes
Liver
A special search was made for the cytological changes described in an earlier
paper (Magee and Barnes, 1956). Large hepatic parenchymal cells with promi-
nent nuclei were found in the livers of rats receiving 50 and 20 p.p.m. DMN both
in the non-tumorous parts of livers with tumours and in those livers without
tumours. However, at lower concentrations of DMN the numbers of large cells
which were seen occasionally in non-neoplastic livers of animals dying late in the
experiment did not differ significantly from the numbers seen in untreated rats.
There are a number of changes which have been described as being frequently
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associated with tumour formation in the liver of animals exposed to chemical
carcinogens (Stewart and Snell, 1957). Of these changes areas of adenofibrosis
were not found but pseudotubules and glandular lesions were seen during the early
stages of exposure to the highest concentrations of DMN (Fig. 1). Slightly
enlarged portal spaces with gland-like structures but without distortion of the
liver architecture were seen in both treated and untreated animals (Fig. 2). The
two changes which were obviously related to exposure to DMN but not clearly
related to each other were tumours and cysts similar to those described by Stewart
and Snell (1957). In Table II these findings are summarised for rats killed or
TABLE II.-The Incidence of Tumnours and Cyst Agglomerates in the Livers
of Rats Receiving DMN in Their Diet
Tumours
DMN Experiment Animals and
p.p.m. Sex weeks total Tumours cysts Cysts Nil
0 F 0-60 4 4
61-120 . 25 . . . 25
M 0-60 . 1 . 1
61-120 . 11 ..11
2 F 0-60 5 5
61-120 . 13 13
M . 0-60 . 6 6
61-120 13 1 . 12
5 F . 0-60 8 8
61-120 69 *5 2 14 48
M 0-60 1 . 1
61-120 5 *1 . 4
10 F . 0-60 . 0
61-120 5 **1 1 2 1
20 F 0-60 10 3 2 1 4
61-120 13 4 *6 1 . 2
50 F 0-60 12 . 4 6 1 1
* Including 1 sarcoma.
** One carcinoma with glandular features.
dying in the first 60 weeks and the second 60 weeks of the various experiments.
Cyst agglomerates were often recognisable to the naked eye and measured up to
2 cm. in diameter. They were multilocular and might replace extensive portions
of the liver parenchyma. The contents of the larger ones were gelatinous. The
cysts were lined with flat or cuboidal epithelial cells and might contain a pale
eosinophilic PAS negative material. Septa between the cysts were thin but some
papillary formation might be seen. Remnants of liver cords were often seen at
the periphery and there was no capsule (Fig. 3 and 4). No nuclear irregularities
were observed. Small isolated subeapsular cysts (Fig. 5) may be found in both
experimental and in untreated rats and are considered to be distinct from the
agglomerates. While the livers of rats on 20 and 50 p.p.m. DMN were grossly
distorted with multiple cysts and tumours, these usually occurred singly in rats
on lower doses. When cysts and tumours occurred together in the same liver the
lesions were quite distinct. Of the 88 rats that received 5 or 10 p.p.m. DMN 19
had cyst agglomerates but only 3 had liver tumours as well; on the other hand of
the 9 rats with tumours only 3 also had cystic agglomerates. Thus these lesions,
while associated with an exposure to DMN, seem to develop independently.
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Hyperplastic nodules (Fig. 6) were seen in 9 rats and in 7 there were also frank
liver tumours making the differential diagnosis difficult but not of particular
importance. Frank hepatomas were seen in 36 rats and the incidence was clearly
dose-dependent in spite of the fact that animals on the lower doses lived longer.
Ofthe tumours 33 were carcinomas ofthe trabecular or anaplastic type. Haemor-
rhage and areas of necrosis were common and metastases were found in the lungs
of 11 rats. In 3 rats the tumours were spindle cell sarcomas with haemorrhage
and necrosis but no metastases were found.
Kidney
No renal tumours were seen. The characteristic senile changes (Magee, 1959)
were noted in rats which survived for more than a year. In 42 rats enlarged
tubules similar to those described by others (Allen, Fisher andAdams, 1964; Foley
et al., 1964, and Terracini, Palestro, Gigliardi and Montesano, 1967) were observed.
These were lined by large epithelial cells with pale uniformly staining cytoplasm
and round nuclei. Small papillae were sometimes seen (Fig. 7). These lesions
appeared irrespective ofthe sex or treatment ofthe rats and were common in the
older rats, although not always associated with the senile changes.
Lungs
In addition to the inflammatory changes and associated bronchiectasis and
liver tumour metastases, a benign primary tumour was found in 4 rats on 2 or
5 p.p.m. DMN. In one a papilloma obstructed a bronchus of a female which also
had a breast tumour. In 3 rats there were small adenomas replacing lung paren-
chyma with the formation ofirregular cavities lined with cuboidal cells with large
nuclei. Although they had no capsule there were no histological signs of malig-
nancy. The tumours were quite distinct from the hyperplasia seen associated
with chronic inflammation.
Other tumours
The incidence of other tumours is given in Table III. There is no obvious
relationship between the site and frequency and the dose of DMN which the
animals had received.
EXPLANATION OF PLATES
FIG. 1. Rat (F). DMN 20 p.p.m. for 50 weeks. Liver: enlarged and confluent portal spaces
with gland formation. H. & E. x 125.
FIG. 2. Rat (F) control killed 115th week. Small cluster of glandular cavities lined by
cuboidal cells in a portal space. H. & E. x 125.
FIG. 3. Rat (F). DMN 5 p.p.m. for 110 weeks. Liver: circumscribed cystic lesion. Cysts
are empty, irregularly shaped and intermingled with liver parenchyma. H. & E. x 50.
FIG. 4.-Rat (F). DMN 5 p.p.m. for 111 weeks. Liver: cyst agglomerate; cysts lined by
flat epithelium are separated by thin fibrous septa. No atypical cells. H. & E. x 140.
FIG. 5.-Rat (F). DMN 5 p.p.m. for 104 weeks. Liver: isolated cyst lined by flat epithelial
cells. This was the only change found in the liver. H. & E. x 140.
FIG. 6.-Rat (F). DMN 20 p.p.m. for 61 weeks. Liver: well defined nodule composed of
sheets of liver cells with no topographical relations to vascular structures or portal spaces.
No atypical cellular features ormitoses. This animal had no liver tumours. H. & E. x 55.
FIG. 7.-Rat (F). DMN 2 p.p.m. for 95 weeks. Kidney: hyperplastic tubule lined by tall
cells with pale cytoplasm. Some nuclei are piled up. P.A.S. x 140.
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DISCUSSION
The exposure of rats to low doses of DMN throughout their life span was
undertaken in order to try to establish a sequence of pathological changes that
might run parallel with the change in tumour incidence. Since the whole liver
of a rat exposed to high doses of DMN undergoes a plethora of histological and
cytological changes in association with the development of tumours, it was hoped
that there might be some widespread non-cancerous changes which would provide
evidence of possible impending malignant transformation. The comprehensive
study of the liver changes in the rats exposed to low doses of DMN revealed no
such indication. While the incidence of tumours fell rapidly when the dose was
decreased from 50 to 5 p.p.m., some malignant tumours were seen at the latter dose
and even at 2 p.p.m. The only other liver changes consistently found were cyst
agglomerates; these were somewhat more frequent than hepatomas in rats on
5 p.p.m. DMN and were not seen at all in those on 2 p.p.m. As indicated above,
these cyst agglomerates appeared to arise quite independently from the hepa-
tomas. It was not possible to detect cytological changes or minor deviation from
normality in hepatic architecture that made it possible to distinguish rats on a
diet containing 2 or 5 p.p.m. DMN that would produce a low incidence oftumours,
and rats on a normal diet ofwhich none in our laboratory has developedhepatomas.
It is very important to try to establish some idea ofthe dose-response relation-
ships to the exposure of animals to carcinogens. However, in most laboratories it
is impractical to expose very large numbers of animals to a carcinogen at doses
that may be expected to produce only a very low incidence (say 1: 1000) of
tumours. Such an incidence would of course represent an appalling hazard to
human populations. Druckrey (1952) has already expressed the view that all
doses of carcinogens are purely additive but attempts to establish the truth ofthis
at low dose levels of a carcinogen are frustrated by the limited life span of the
experimental animals. The use of specific pathogen-free rats and mice with a
longer life span will provide more opportunities for doing such studies. However,
the simple concept of the additive effect of repeated doses is not applicable to
every situation. The incidence of kidney tumours in rats given DMN illustrates
such an exception.
Among rats surviving a single intraperitoneal LD50 of DMN (6 mg.) 20%
developed kidney tumours while a much higher incidence was seen in rats receiving
a diet containing 200 p.p.m. DMN for 1 week (21 mg.) or 100 p.p.m. for 4 weeks
(42 mg.) (Magee and Barnes, 1962). Furthermore, Jasmin and Riopelle (1964)
found 100% incidence in rats given 1-5 mg. DMN daily for 6 days only (9 mg.).
In the experiments described here no kidney tumours were found in rats receiving
5 p.p.m. DMN for up to 104 weeks (54 mg.). (The total dose of DMN given in
parentheses is calculated on the basis of a daily intake of 15 g. of diet.) Thus
the total dose of carcinogen ingested is not always the only factor in producing
tumours. It is probable that the crucial factor is the amount of the carcinogen
which reaches the site ofaction as has been accepted for other drug effects (Brodie,
Cosmides and Rall, 1965). In the case of DMN which almost certainly has to be
-metabolised before it becomes carcinogenically active it has long been known that
-the metabolism of a second dose ofDMN is slowed when it follows closely after the
first dose (Magee, 1956). Under these circumstances it is easy to visualise an
effective dose reaching the kidneys.
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The main object ofthese long-term studies on the effect oflow doses ofcarcino-
gens was to try to provide a basis from which to extrapolate a no-effect dose. The
present work indicates that in the case of the liver and the active nitrosamines,
morphological changes cannot provide a basis for recognising effects before the
appearance oftumours. Any hope ofestablishing a no-effect dose ofa carcinogen
must rest upon finding out more about the biochemical changes that must precede
the development ofneoplasia with the hope ofbeing able to establish a dose below
which such biochemical disturbances do not take place.
SUMMARY
1. The pathological changes in rats kept for a lifetime on diets containing 5 and
2 p.p.m. dimethylnitrosamine (DMN) are described.
2. While the incidence of liver tumours falls rapidly when the dietary concen-
tration of DMN is reduced from 50 to 5 p.p.m. a single rat on 2 p.p.m. developed
a liver tumour so that a no-effect level has not been established.
3. There were no pathological changes in the liver other than tumours which
provided a more sensitive index of exposure to DMN.
4. No kidney tumours were seen in any rats and the dose response relationship
for DMN and tumours of the kidney is discussed.
We wish to thank Mr. C. R. Kennedy for his constant attention to the animals
and their diets during these experiments; Mr. R. Legg for the photographs and
Mr. J. A. E. Jarvis for making the determination ofDMN in the diets.
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